|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:awards
|
industry recognition
|
|
gptkbp:ceo
|
gptkb:Xiaoming_Yang
|
|
gptkbp:clinical_phase
|
Phase III trials
|
|
gptkbp:clinical_trial
|
gptkb:China
gptkb:vaccine
thousands
regulatory bodies
published in journals
Phase II trials
high efficacy rates
|
|
gptkbp:clinical_trials_data
|
analyzed by experts
|
|
gptkbp:clinical_trials_outcomes
|
positive results
|
|
gptkbp:collaboration
|
gptkb:Academy_of_Military_Medical_Sciences
|
|
gptkbp:collaborations
|
gptkb:WHO
various universities
|
|
gptkbp:community_engagement
|
health education programs
|
|
gptkbp:employees
|
over 200
|
|
gptkbp:focus
|
vaccine development
|
|
gptkbp:focus_area
|
emerging infectious diseases
|
|
gptkbp:founded
|
gptkb:2009
|
|
gptkbp:funding
|
government grants
private investors
|
|
gptkbp:global_health_impact
|
gptkb:significant
|
|
gptkbp:goal
|
improve public health
|
|
gptkbp:headquarters
|
gptkb:Tianjin,_China
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cansino Biologics Inc.
|
|
gptkbp:invention
|
multiple vaccine patents
|
|
gptkbp:investment
|
various venture capital firms
R& D
|
|
gptkbp:market
|
global
|
|
gptkbp:marketing_strategy
|
global expansion
|
|
gptkbp:notable_products
|
gptkb:Ad5-n_Co_V
|
|
gptkbp:partnership
|
gptkb:Can_Sino_Biologics_(Canada)_Inc.
|
|
gptkbp:partnerships
|
international organizations
|
|
gptkbp:product
|
gptkb:Ad5-EBOV
|
|
gptkbp:product_line
|
vaccines
|
|
gptkbp:product_type
|
biopharmaceuticals
|
|
gptkbp:publication
|
numerous
|
|
gptkbp:regulatory_compliance
|
multiple countries
|
|
gptkbp:research_areas
|
infectious diseases
|
|
gptkbp:research_institutes
|
gptkb:Tianjin_Medical_University
|
|
gptkbp:supply_chain
|
global suppliers
|
|
gptkbp:sustainability_efforts
|
environmental responsibility
|
|
gptkbp:technology
|
viral vector technology
|
|
gptkbp:traded_on
|
gptkb:Hong_Kong_Stock_Exchange
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:vaccine_distribution
|
gptkb:international_partners
|
|
gptkbp:vaccine_effectiveness
|
demonstrated in studies
|
|
gptkbp:vaccine_innovation
|
cutting-edge technology
|
|
gptkbp:vaccine_research
|
ongoing
|
|
gptkbp:vaccine_safety
|
monitored by authorities
|
|
gptkbp:vaccine_storage
|
standard refrigeration
|
|
gptkbp:vaccine_type
|
gptkb:recombinant_vaccine
|
|
gptkbp:website
|
www.cansinotech.com
|
|
gptkbp:bfsParent
|
gptkb:Can_Sino_Biologics
|
|
gptkbp:bfsLayer
|
6
|